Theralink Technologies, Inc. THER OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

24/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Theralink Technologies, Inc. (THER) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 22/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

24/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

MOAT

50/100

→ Income

GROWTH

58/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — THER

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio1.01

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.01

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2014	$-7.24	$254.00	$-453.88K	-178692.5%
2015	$-15.08	$74.00	$-990.4K	-1338373%
2016	$-25.91	$0.00	$-2.01M	-
2017	$-119.37	$0.00	$-20.51M	-
2018	$9.13	$0.00	$6.47M	-
2019	$-22.63	$0.00	$-11.2M	-
2020	$-0.04	$181.23K	$-3.21M	-1772.1%
2021	$0.00	$505.6K	$-5.59M	-1106.2%
2022	$0.00	$567.91K	$-12.75M	-2245%
2023	$-0.01	$606.8K	$-30.91M	-5093.6%